What is Man Alive?
Man Alive, Inc. operates at the intersection of clinical medicine and behavioral health, providing comprehensive, evidence-based treatment services for individuals navigating substance use recovery. The company distinguishes itself through a multi-modal approach that includes the administration of Methadone, Suboxone, and Sublocade, alongside a robust Health Home Program. Central to its operational strategy is the integration of Peer Recovery Specialists and innovative hardware solutions, such as the Robotic Methadone Dose Assembly System, which enhances precision and safety in medication delivery.
By addressing the complex needs of patients through both pharmacological and psychosocial support, Man Alive, Inc. has established itself as a critical infrastructure provider in the addiction recovery sector. Its commitment to evidence-based methodologies ensures that treatment protocols are not only effective but also scalable, allowing the organization to serve a diverse patient population with varying levels of acuity.
How much funding has Man Alive raised?
Man Alive has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Man Alive
PPP
Public-Private Partnership
What's next for Man Alive?
With the successful closure of this major strategic investment, Man Alive, Inc. is poised to accelerate its expansion strategy. The company is expected to prioritize the deployment of its Robotic Methadone Dose Assembly System across new clinical sites, thereby increasing operational efficiency and patient throughput. Furthermore, the capital will likely support the enhancement of its Health Home Program, facilitating deeper integration with regional healthcare networks and improving long-term patient outcomes.
Looking ahead, the firm is well-positioned to capitalize on the increasing demand for specialized addiction treatment services. By maintaining its focus on clinical excellence and technological innovation, Man Alive, Inc. aims to solidify its leadership in the behavioral health market, potentially exploring new geographic territories and diversifying its service offerings to meet the evolving requirements of the recovery community.
